NCT02811211

A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD

A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,894 (actual)
• Sponsor: Aevi Genomic Medicine, LLC, a Cerecor company · Industry
• Sex: All
• Age: 6 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

This noninterventional study will assess genomic changes in the metabotropic glutamate receptor (mGluR) network in children and adolescents with ADHD.

Detailed description

Male and female subjects 6 to 17 years of age with a primary psychiatric diagnosis of ADHD will be enrolled in this study. The subject and his or her parent/guardian must agree to genotyping to determine whether the subject has disruptive mutations within any of the approximately 274 mGluR-network genes, and complete an interview that will include information about the subject's ADHD history, treatment, and co-morbidities.

Conditions

• Attention Deficit Disorder With Hyperactivity

Timeline

• Start date: 2016-02-01
• Primary completion: 2017-01-06
• Completion: 2017-01-06
• First posted: 2016-06-23
• Last updated: 2021-07-06

Locations

1 site across 1 country: United States